Abstract | INTRODUCTION: METHODS: We studied eight prospective cohorts with 22,623 participants profiled by nuclear magnetic resonance or mass spectrometry metabolomics. Four cohorts were used for discovery with replication undertaken in the other four to avoid false positives. For metabolites that survived replication, combined association results are presented. RESULTS: DISCUSSION: Further studies can clarify whether these molecules play a causal role in dementia pathogenesis or are merely markers of early pathology.
|
Authors | Juho Tynkkynen, Vincent Chouraki, Sven J van der Lee, Jussi Hernesniemi, Qiong Yang, Shuo Li, Alexa Beiser, Martin G Larson, Katri Sääksjärvi, Martin J Shipley, Archana Singh-Manoux, Robert E Gerszten, Thomas J Wang, Aki S Havulinna, Peter Würtz, Krista Fischer, Ayse Demirkan, M Arfan Ikram, Najaf Amin, Terho Lehtimäki, Mika Kähönen, Markus Perola, Andres Metspalu, Antti J Kangas, Pasi Soininen, Mika Ala-Korpela, Ramachandran S Vasan, Mika Kivimäki, Cornelia M van Duijn, Sudha Seshadri, Veikko Salomaa |
Journal | Alzheimer's & dementia : the journal of the Alzheimer's Association
(Alzheimers Dement)
Vol. 14
Issue 6
Pg. 723-733
(06 2018)
ISSN: 1552-5279 [Electronic] United States |
PMID | 29519576
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Amino Acids, Branched-Chain
- Biomarkers
- Lipoproteins
|
Topics |
- Adult
- Aged
- Alzheimer Disease
(metabolism, pathology)
- Amino Acids, Branched-Chain
(metabolism)
- Biomarkers
(metabolism)
- Dementia
(metabolism, pathology)
- Humans
- Lipoproteins
(metabolism)
- Magnetic Resonance Imaging
- Mass Spectrometry
- Metabolomics
(methods)
- Middle Aged
- Prospective Studies
- Risk Assessment
- Risk Factors
|